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Abstract
Background: The development of accurate epitope prediction tools is important in facilitating disease diagnostics,
treatment and vaccine development. The advent of new approaches making use of antibody and TCR sequence
information to predict receptor-specific epitopes have the potential to transform the epitope prediction field.
Development and validation of these new generation of epitope prediction methods would benefit from regularly
updated high-quality receptor-antigen complex datasets.
Results: To address the need for high-quality datasets to benchmark performance of these new generation of
receptor-specific epitope prediction tools, a webserver called SCEptRe (Structural Complexes of Epitope-Receptor)
was created. SCEptRe extracts weekly updated 3D complexes of antibody-antigen, TCR-pMHC and MHC-ligand from
the Immune Epitope Database and clusters them based on antigen, receptor and epitope features to generate
benchmark datasets. SCEptRe also provides annotated information such as CDR sequences and VDJ genes on the
receptors. Users can generate custom datasets based by selecting thresholds for structural quality and clustering
parameters (e.g. resolution, R-free factor, antigen or epitope sequence identity) based on their need.
Conclusions: SCEptRe provides weekly updated, user-customized comprehensive benchmark datasets of immune
receptor-epitope structural complexes. These datasets can be used to develop and benchmark performance of
receptor-specific epitope prediction tools in the future. SCEptRe is freely accessible at http://tools.iedb.org/sceptre.
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Background
B and T cell responses are essential components of
adaptive immunity which can provide long term protec-
tion against various pathogens. Antibodies and T-cell re-
ceptors (TCRs) are expressed by B and T cells,
respectively, to recognize an ever-changing collection of
antigens. Antibodies and TCRs recognize a specific re-
gion of the antigen, known as an epitope, with their
binding site, known as a paratope. Identification of epi-
topes is of high importance for many medical, immuno-
logical and biological applications including disease
control, diagnostics, and vaccine development [1, 2].
The best performing antigen sequence and structure-
basedB-cell epitope prediction tools, such as BepiPred,
DiscoTope, ABCpred and CBtope [3–6], have limited
predictive power [4]. These B cell epitope prediction
tools predict the surface patch on the antigen that can
be a target of one or more antibodies out of likely sev-
eral billion antibodies from the host. Given this immense
antibody repertoire, most antigen surface patches can be
targets of host antibodies and this property is one of the
main reasons behind the poor performance of B cell epi-
tope prediction methods [7]. In contrast, T cell epitope
predictions rely predominantly on MHC binding predic-
tions [8–10]. MHC binding is necessary but not enough
to induce an immune response. An appropriate T-cell
clone that can recognize a specific peptide-MHC
(pMHC) complex is needed to induce an immune
response.
Recent advances in the sequencing of immune recep-
tor repertoire [11] have raised interest to identify epi-
topes by predefined antibodies and TCRs. Therefore, a
new generation of B and T cell epitope prediction
methods have shifted focus from predicting general
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epitopes in antigens to predicting epitopes for a specific
receptor [12, 13]. Recently, several antibody- and TCR-
specific epitope prediction methods have become avail-
able [7, 13–15]. Currently, the data needed to train and
validate these methods are scarce and often repetitive.
The receptor-specific epitope prediction methods utilize
different clustering approaches to remove the redun-
dancy in their training and testing datasets which makes
it difficult to reliably compare and evaluate results from
multiple prediction methods. There is also a need to
evaluate the performance of these methods on independ-
ent datasets. However, the definition of such independ-
ent datasets is often non-trivial, because the
methodologies and/or datasets used to train and develop
the different tools are not completely available.
The Immune Epitope Database (IEDB) is a free public
resource which captures experimental immune epitope
and epitope-specific receptor data that is manually cu-
rated [16, 17]. While other 3D structural databases con-
taining antibody and TCR information exist [18–20], the
IEDB integrates these data with all other kinds of epi-
tope mapping experiments and includes standardized
definitions for the epitopes identified for each of them,
includes manual quality checks for each data element,
and allows users to bulk download the database. As of
June 2019, IEDB has over 585,000 epitopes from over
20,300 manually curated references. IEDB also provides
calculated intermolecular contacts and interface areas
for 3D structures of receptor-antigen complexes. Such
atomic-level details of receptor-antigen complexes are
important to our understanding of the epitope recogni-
tion mechanism by immune receptors.
To address the need for high-quality datasets to
benchmark performance of the receptor-specific epitope
prediction tools, a webserver, called SCEptRe (Structural
Complexes of Epitope-Receptor) was developed. Hier-
archical clustering was used to develop comprehensive
non-redundant datasets of receptor-epitope complexes
based on the antigen, epitope and receptor sequence
and/or structural features.
Results
Receptor-antigen complexes in the IEDB
The IEDB was used to extract experiments characteriz-
ing immune receptor-antigen 3D complexes. A total
2510 Ab-Ag, 296 TCR-pMHC and 1107 MHC-ligand
complexes curated in the IEDB, as of June 2019, were
extracted. These complexes included 319 Ab-Ag, 115
TCR-epitope-MHC and 147 MHC-ligand complexes
with non-peptidic antigens, which are further discussed
at the end. For peptidic epitopes, receptor-antigen 3D
complexes were further filtered based on default thresh-
olds for resolution, antigen or linear epitope sequence
length and missing residues in the CDR regions as de-
scribed in the following sections.
Ab-Ag dataset
Out of all the 2510 Ab-Ag complexes, total 2191 Ab-Ag
complexes with peptidic epitopes from the IEDB were
filtered to remove poor resolution structures using a de-
fault 3 Å threshold. Ab-Ag complexes with antigens with
less than 50 residues and missing residues in the anti-
body CDR regions were also removed from the dataset.
Out of the 772 Ab-Ag complexes after filtering were
clustered based on their antigen sequence identity, anti-
body CDR sequences and epitope 3D conformational
similarity. Antigen sequences were clustered independ-
ently using 70% sequence identity threshold into 338
distinct groups. All available antibodies were clustered
into 479 distinct groups based on their CDR sequences
and their corresponding epitopes were further clustered
based on the 3D conformational similarity using Pocket-
Match [21] into 727 distinct antibody-epitope groups
(Table 1).
TCR-pMHC dataset
From the dataset of 181 TCR-pMHC complexes from
the IEDB with peptidic epitopes, low resolution com-
plexes were removed using 3 Å resolution threshold.
TCR-pMHC complexes with core-epitopes less than 8
residues and CDRs with missing residues were also fil-
tered out from the dataset. A total of 154 TCR-pMHC
complexes after filtering were further clustered based on
their core-epitope sequence similarity, CDR and MHC
G-domain sequences into 105 distinct clusters including
98 distinct TCR-epitope groups (Table 1). These clusters
included 63, 79 and 33 distinct groups of T cell core-
epitopes, TCRs and MHC molecules, respectively.
MHC-peptide dataset
Similar to TCR-pMHC complexes, MHC-peptide com-
plexes with more than 3 Å resolution and less than 8
residue core-epitopes were not considered for further
clustering. Out of 960 total MHC-peptide complexes,
the remaining 861 MHC-peptide complexes after filter-
ing were further clustered based on their core-peptide
sequence similarity, and MHC G-domain sequences into
439 distinct clusters (Table 1). These clusters included
342 and 133 distinct groups of core-peptides and MHC
molecules, respectively.
Non-peptidic epitope or ligand datasets
A total of 319 Ab-Ag complexes with non-peptidic epi-
topes were filtered based on resolution and missing resi-
dues in the antibody CDR regions. The remaining
antibody sequences from 281 Ab-Ag complexes were
clustered into 154 distinct antibody groups based on
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their CDR sequences. Similarly, all the 115 TCR-pMHC
complexes with non-peptidic ligands were filtered based
on 3 Å resolution threshold and no missing residues in
the CDR regions. The remaining 85 TCR-pMHC com-
plexes were clustered into 28 TCR and 7 MHC distinct
groups. A total of 147 MHC-ligand complexes with non-
peptidic ligands were filtered based on their resolution
to 126 complexes. These 126 MHC-ligand complexes
were clustered based on their MHC sequences into 18
distinct groups.
Webserver
A webserver, named SCEptRe (Structural Complexes of
Epitope-Receptor), was developed and made available in
the IEDB analysis resource [22] to provide weekly up-
dated receptor-antigen 3D complexes (Fig. 1). SCEptRe
can be accessed at http://tools.iedb.org/sceptre. All the
structural quality parameters such as resolution, missing
residues in CDRs used for filtering receptor-antigen
complexes, were made available through SCEptRe. In
addition, filtering based on R free factor was added to
the webserver. The antigen and epitope/ligand filtering
and clustering parameters were also made available.
Additionally, MHC feature parameters, namely, source
organism and MHC class for TCR-pMHC and MHC-
ligand 3D complexes were also provided to users. An
option to select receptor-antigen complexes with pep-
tidic or non-peptidic epitopes/ligands was also added to
the webserver. All the default filtering and clustering pa-
rameters discussed in the Methods sections were pro-
vided as recommended values in the online webserver,
where they can be modified by the user if needed.
Results are shown as a table with links to IEDB assay,
epitope and receptor details pages, along with a link to
Table 1 Immune receptor-antigen 3D complexes
Type of complex Antibody-antigen TCR-pMHC MHC-ligand
Total available complexes 2510 296 1107
Complexes with peptidic ligand 2191 181 960
Complexes after filtering 772 154 861
Distinct receptor-epitope pairs 727 98 439
All the receptor-antigen complexes were filtered at 3 Å resolution, along with complexes with missing residues in the antibody or TCR CDR regions. Remaining
antibody-antigen complexes with antigens with less than 50 residues were further removed from the dataset. TCR-pMHC and MHC-ligand complexes with core-
epitope sequences shorter than 8 residues were removed from the final dataset
Fig. 1 SCEptRe webserver: Users can customize various parameters to filter and cluster (a) antibody-antigen 3D complexes (b) TCR-pMHC
complexes and (c) MHC-ligand complexes using the online resource. Recommended parameters are provided as default values in the webserver
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PDB website. The 3D structure of receptor-antigen com-
plexes can be visualized using the IEDB JSmol viewer
(JSmol: an open-source HTML5 viewer for chemical
structures in 3D. http://wiki.jmol.org/index.php/JSmol)
(Fig. 2) which provides options to inspect one or all
interacting residues in the receptor-antigen complexes.
Discussion
The advances in the technology to sequence B and T cell
receptor repertoires from individuals has led to the de-
velopment of receptor-specific B and T cell epitope pre-
diction methods. These new epitope prediction methods
would benefit from regularly updated high-
qualityreceptor-antigen datasets. Resources like the
IEDB provide manually curated data on experimental in-
formation of antigen-receptor complexes. SCEptRE pro-
vides several down-stream processing steps to filter data
from the IEDB to retain high-qualityreceptor-antigen
complexes. SCEptRE also provides approaches to clus-
tering the receptor-antigen 3D complexes so that these
datasets can be used directly to train and validate
receptor-specific epitope prediction methods.
Currently available 3D receptor-antigen complex
datasets cluster antibody and TCR sequences based
on their full-length sequences [7, 13, 23, 24]. Anti-
body and TCR sequences with identical CDRs may
be grouped in different clusters by such an ap-
proach. CDRs interact directly with the antigen and
are linked to the specificity of B and T cell receptors
[25, 26]. It is also known that antibody heavy- and
TCR β chains make the most extensive contacts with
the antigen. Hence, SCEptRe classifies receptors
based on their CDR sequences. Receptor cluster
identifiers include information on the individual
heavy, light, α or β chain clusters so that users can
re-cluster them based on their need, e.g. heavy chain
only or β chain only groups.
SCEptRe also addresses the lack of grouping of B cell
epitopes based on their 3D conformational similarity in
the currently available antibody-antigen complex data-
sets. Cross-reactive antibody bound to conformationally
similar epitopes from homologous antigens can provide
similar Ab-Ag contacts residue pairs. Such Ab-Ag com-
plexes can be grouped together by the conformational
similarity between their epitopes.
Over the year, different MHC allele nomenclatures
have been used by the scientific community to describe
MHC molecules. SCEptRe introduces a sequence-based
approach to apply a consistent classification of MHC
molecules for TCR-pMHC and MHC-ligand complexes
instead of relying on the reported identify of MHC mol-
ecules to provide consistent MHC molecule clusters.
Fig. 2 The IEDB JSmol viewer can be used to manually inspect receptor-antigen interactions. The blue colored spheres in the antibody-antigen
complex (PDB ID: 1XIW) shown in the figure represent the epitope residues and yellow spheres are paratope residues in direct contact with each
other. Individual interacting residues can be selected using the right-side panel
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Conclusions
SCEptRe provides user-customized, weekly updated,
non-redundant datasets of receptor-antigen 3D com-
plexes along with annotated receptor information. The
datasets provided by SCEptRe can be used to develop
and benchmark performance of receptor-specific epitope
prediction tools in the future. The clustering of the
receptor-antigen complexes can be used to remove re-




An automated query was set up which extracts the
antibody-antigen, TCR-pMHC and MHC-ligand assays
from the IEDB SQL database for which 3D structures
were available. Information related to host organisms,
source antigens, epitopes, receptor’s CDR sequences and
VDJ genes along with PDB ID, resolution and calculated
receptor-antigen contacts (using 4 Å distance) were re-
trieved. The calculated receptor-antigen contacts are
inspected manually in the IEDB curation process to
check and remove irrelevant contacts which are not part
of antigen-receptor interactions, especially in cases of
engineered antibody, TCR or MHC constructs. The R
free factors of the complexes were extracted from their
PDBx/mmCIF files and added to the SQL query output
files. Further, all the receptor-antigen 3D complexes
were filtered to remove poor quality structures.
Receptor-antigen complexes with peptidic antigens
(which includes full-length proteins but excludes non-
peptidic small molecules) were further clustered based
on their receptor and antigen features to identify distinct
receptor-epitope pairs. Conversely, receptor-antigen
complexes with non-peptidic epitopes were clustered
separately based on their receptor features.
Antibody-antigen (Ab-Ag) complexes
The antibody chain sequences were numbered using
ANARCI [27] and CDRs were identified using the IMGT
numbering [28]. Antibody CDR sequences were mapped
to their 3D structures. Filters to exclude low-quality
structures included, resolution (default: 3 Å) and op-
tional removal of complexes with missing backbone
atoms in the CDR regions (default: remove). Ab-Ag
complexes with short antigen protein sequences can fur-
ther be filtered (default: exclude antigens with < 50
amino acid residues).
The remaining Ab-Ag complexes were clustered based
on their antigen sequences using the Cluster tool [29]
with a sequence identity threshold (default: 70%). Fur-
thermore, all Ab-Ag complexes were clustered based on
the antibody CDR sequences. Antibody heavy and light
chains with identical CDR sequences were grouped
independently and their clusters were denoted using ‘H’
and ‘L’ prefixes, respectively. For example, antibody clus-
ter H1_L1, where H1 is the first heavy chain cluster and
L1 is the first light chain cluster.
PocketMatch (version 2) was used to identify confor-
mationally similar B cell epitopes [21]. PocketMatch cal-
culates all against all-atom distance pairs in the 2
binding sites and then compares sorted lists of distances
to identify the conformationally similar binding site.
Two types of scores, PMax and PMin, are provided by
PocketMatch. PMax score is the ratio of matched dis-
tance pairs in the 2 binding sites over the total number
of distance pairs in the longer binding site. Conversely,
PMin score is the ratio of matched distance pairs in 2
binding sites over a total number of distance pairs in the
shorter binding site. Both PMax and PMin scores were
used to cluster B cell epitopes within each antibody clus-
ter to generate unique antibody-epitope pairs. Pairs of B
cell epitopes from each antibody cluster were clustered
together if their PMax or PMin score was 1.0, or PMin
score was at least 0.9 and PMax score was at least 0.6.
TCR-pMHC complexes
Like Ab-Ag complexes, CDR sequences were identified
by numbering TCR chain sequences using ANARCI with
IMGT numbering. TCR-pMHC complexes were filtered
to exclude low-quality structures based on resolution
(default: 3 Å) and presence of missing backbone atoms
in the CDR regions (default: remove). Additionally, core-
epitopes were defined to ignore the overhangs of the
antigenic peptides that do not directly interact with
MHC or TCR molecules. The core-epitope definition in-
cluded all residues between the first and last residues on
the antigen chain within 4 Å distance of any atom in
MHC or TCR molecules. TCR-pMHC complexes with
core-epitope sequences shorter than a defined number
of residues (default: 8 residues) were removed from the
dataset.
The remaining TCR-pMHC were clustered based on
core-epitope sequences using Cluster tool with a se-
quence identity threshold of (default: 85%). TCR α and β
chains with identical sequences were clustered. Like
antibody clustering, TCRs were clustered based on their
α and β chain CDRs independently and were denoted by
‘A’ and ‘B’ prefixes, respectively.
The α1-α2 and α1-β1 domains in the MHC class I and
II molecules, respectively, are known as groove or G-
domains [30]. The ligand-binding site of MHC mole-
cules are part of the G-domains and hence are respon-
sible for their specificity. All the available G-domain
sequences from IMGT [31] were downloaded. MHC
chain sequences from TCR-pMHC complexes were
searched against these datasets of G-domains using
BLAST [32]. The BLAST parameters such as e-value of
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1.00E-10, query coverage threshold of 90% and subject
coverage threshold of 85% were used to align input
MHC sequences to known G-domains. Regions of the
MHC sequences mapped to the first G-domain hits were
extracted and used to cluster TCR-pMHC complexes.
MHC class I molecules with identical α1-α2 domains
were clustered together and were denoted using prefix
‘a’. Similarly, MHC class II molecules with identical α1
and β1 domains were clustered together and denoted
with ‘a’ and ‘b’ prefixes, respectively. For non-classical
MHC molecules (for example, human CD1a), their
complete protein sequences were used for clustering and
the groups were denoted using ‘n’ as a prefix.
MHC-peptide complexes
The core-peptides were defined for MHC-peptide com-
plexes as a range of residues between the first and last
residues on antigen chain within 4 Å distance of any
atom in MHC molecules. MHC-peptide complexes with
core-peptides shorter than 8 residues were removed
from the dataset. The MHC-peptide complexes were
clustered based on core-peptides using a sequence iden-
tity threshold (default: 85%), like core-epitopes in TCR-
pMHC complexes. Further, these complexes were clus-
tered based on MHC G-domains, like MHC G-domain
sequence clustering in TCR-pMHC complexes.
Complexes with non-peptidic antigens
All the complexes with non-peptidic epitopes were fil-
tered based on resolution (default: 3 Å) and presence of
missing residues in the CDR regions (default: remove).
The remaining complexes were clustered based on their
receptor CDR sequences and MHC molecules, where
applicable, as described in earlier sections.
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